Resolute Holdings Management (RHLD) investor relations material

Executive summary

• Completed the acquisition of Husky Holdings, expanding into injection molding equipment and services, and entered a management agreement with Husky Holdings on terms similar to the existing CompoSecure agreement.

• Net sales for Q1 2026 rose 292% year-over-year to $407.8M, driven by the Husky acquisition and organic growth at CompoSecure.

• Net income attributable to common stockholders was $61.5M, reversing a loss of $3.4M in Q1 2025.

• Achieved diluted EPS of $7.19, up from $(0.39) year-over-year, and Non-GAAP Fee-Related EPS of $0.69, up from $(0.07), driven by new management agreements and organic fee growth.

• Repurchased $38.0M in common shares during the quarter.

Financial highlights

• Net sales: $407.8M, up from $103.9M year-over-year.

• Gross profit: $155.6M, up from $54.5M year-over-year.

• Operating loss: $(5.8)M, down from $25.6M operating income in Q1 2025.

• Diluted EPS: $7.19, up from $(0.39).

• Cash and equivalents at quarter-end: $120.1M; total debt: $2,215.0M.

Outlook and guidance

• Management expects continued benefits from the Husky acquisition, including revenue diversification and scale, and recurring, long-duration management fees to support future profitability.

• Cautions on ongoing macroeconomic and geopolitical risks, including supply chain disruptions, inflationary pressures, and fee fluctuations.

• Liquidity at both Resolute Holdings and GPGI Holdings is expected to be sufficient for at least the next 12 months.